Mortality statistics from national censuses: a low cost viable method.
@article{Kandel2010MortalitySF, title={Mortality statistics from national censuses: a low cost viable method.}, author={N Kandel and Neetu Singh and Anton Fri{\vc}}, journal={Journal of Nepal Health Research Council}, year={2010}, volume={8 1}, pages={ 63-8 } }
Information related to mortality is pivotal for evidence based policy and planning, resource mobilization and impact of intervention. This information is essential to monitor trends in health situation of the population, detect new epidemics, encourage research into avoidable causes of death, evaluate the success of control programs, and improve accountability for expenditures on disease control. Sixty percent of the countries of the world don't provide enough information on vital events and…
References
SHOWING 1-10 OF 14 REFERENCES
Reliable mortality data: a powerful tool for public health.
- Medicine, Political ScienceThe National medical journal of India
- 2001
In this issue of the Journal, Mahapatra and Chalapati Rao provide an important and timely examination of the coverage and quality of COD reporting in the now defunct Survey of Causes of Death (Rural) and the Medically Certified Causes of death (MCCD) which covers mainly urban centres.
Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics.
- MedicineBulletin of the World Health Organization
- 2005
Sample vital registration (SVR), when applied in conjunction with validated verbal autopsy procedures and implemented in a nationally representative sample of population clusters represents an affordable, cost-effective, and sustainable short- and medium-term solution to this problem.
Monitoring trends in under-5 mortality rates through national birth history surveys.
- Medicine, EconomicsInternational journal of epidemiology
- 2004
DHS birth history surveys with their present sampling design would be able to statistically confirm under-5 mortality reductions in African countries if true reductions were 15% or larger, and are highly relevant to tracking progress towards existing international child health targets.
Prospective Study of One Million Deaths in India: Rationale, Design, and Validation Results
- MedicinePLoS medicine
- 2006
This study will reliably document not only the underlying cause of child and adult deaths but also key risk factors (behavioral, physical, environmental, and eventually, genetic) and strengthens India's flagship mortality monitoring system.
Health and economic benefits of an accelerated program of research to combat global infectious diseases
- MedicineCanadian Medical Association Journal
- 2004
The role scientific research has played in the historic rates of decline in infectious disease mortality during the 20th century is reviewed and the economic benefits of disease control are discussed, including the likely benefits of accelerated research.
Verbal autopsy of 80,000 adult deaths in Tamilnadu, South India
- MedicineBMC public health
- 2004
Verbal autopsy worked very well in Tamilnadu, to arrive at the probable underlying cause of death reliably for deaths in early adult life or middle age and less reliably for older ages (70+).
World mortality 1950-2000: divergence replaces convergence from the late 1980s.
- Political ScienceBulletin of the World Health Organization
- 2005
The switch in the late 1980s from the global convergence of life expectancy at birth to divergence indicates that progress in reducing mortality differences between many populations is now more than offset by the scale of reversals in adult mortality in others.
Monitoring global health: time for new solutions
- Political Science, MedicineBMJ : British Medical Journal
- 2004
Improved global health monitoring requires new technologies and methods, strengthened national capacity, norms and standards, and gold standard global reporting. The World Health Organization's many…
Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.
- Medicine, BiologyThe New England journal of medicine
- 1981